Barsouk A, Heidlauf A, Goel K, Rushkin L, Anran Huang A, Elghawy O, Yu C, Wang L, Yang D, Kurian M, Reed-Guy L, Sun L, Singh A, Aggarwal C, Cohen RB, Langer C, Marmarelis ME. Osimertinib dose-reduction and survival in 1L EGFR-mutated metastatic non-small cell lung cancer (mNSCLC) , Lung Cancer: 2026
Barber-Rotenberg JS, Haas AR, Aggarwal C, O'Hara M, Hexner E, Pequignot E, Dowd E, Ndeupen S, Thai E, Chen F, Oner BS, Czuczman C, Gonzalez VE, Fraietta JA, Hwang WT, Chew A, Jadlowsky JK, Marshall A, Shea KM, Jiang Y, Cosey A, Ferthio R, Levine BL, Plesa G, Siegel DL, Young RM, Sheppard NC, Albelda SM, June CH, Tanyi JL. Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers , Mol Ther: 2026
Aggarwal C, Ng S, Kamalakar R, Beruti S, Simmons A, Beasley MB. A United States-Based Real-World Study on Biomarker Testing and Rebiopsy Rates Among Patients With Non-Small Cell Lung Cancer Across Lines of Therapy , Clin Lung Cancer: 2026
H. Grover ∙ A. Kumar ∙ M. Krishna ∙ P. Kumari ∙ S. Chandrashekaraiah ∙ A. Chakraborty ∙ J. Chauhan ∙ V. Patil ∙ V.P. Shyamasundar ∙ S. Kulkarni ∙ S. Kapoor ∙ J. Wingrove ∙ Y. Mundkur ∙ T. Patil ∙ C. Aggarwal Cellular Heterogeneity and Tertiary Lymphoid Structure Dynamics Predict Overall Survival in Immune Checkpoint Therapy-Treated NSCLC Patients , Journal of Thoracic Oncology, 20(10): 2025
Singh A, Horng H, Roshkovan L, Hershman M, Cohen EA, Aggarwal C, Carpenter EL, Katz SI, Kontos D. Development of a prognostic multiomic biomarker of progression-free survival in advanced non-small cell lung cancer patients treated with first line immunotherapy , Sci Rep, 15: 2025,34591
Aggarwal C, Desai A, McConnell N, Cadirov N, Gustavsen G, Agarwal A, Chehab N, Kotapati S, Patel N. Clinician Perspectives on Digital and Computational Pathology: Clinical Benefits, Concerns, and Willingness to Adopt , Diagnostics (Basel), 15: 2025,2527
C. Aggarwal, D. Watson, P. Nair, A. Kumar, S. Khandelwal, J. Chauhan, S. Khanna, S. George, A. Dey, M. Patil, N. Ganesh, R. Purushottam, S. Kulkarni, P. G, D.A. Lala, S. Basu, S. Kapoor, M. Castro, J. Wingrove, T. Patil Computational Modeling of Comprehensive Genomic Profiling to Predict Chemotherapy Benefit in Advanced NSCLC , Journal of Thoracic Oncology, 20(10): 2025
N.F. Abdel Karim ∙ C. Aggarwal ∙ A. Kobayashi ∙ C. Pompili ∙ D. Molena ∙ E. Shum ∙ G. Friedrich ∙ H. Wakelee ∙ J.R. Brahmer ∙ L. Woldmann ∙ M. Boron ∙ N. Florez ∙ P. Garrido ∙ R. Shenolikar ∙ S. Peters14 ∙ J. Naidoo ∙ M.L. Hsu ∙ E. Felip Gender Differences in Lung Cancer Diagnosis, Treatment Patterns and Outcomes: A Systematic Literature Review , Journal of Thoracic Oncology, 20(10): 2025
Anagnostou V, Aggarwal C. Toward Response-Adaptive Therapy in Locally Advanced NSCLC: Integrating ctDNA and Radiomics for Risk Stratification , Cancer Discov, 15: 2025,1534-1536
Aggarwal C, Martinez-Marti A, Majem M, Barlesi F, Carcereny E, Chu Q, Monnet I, Sánchez-Hernández A, Dakhil S, Camidge DR, Pillet M, Brown M, Paliompeis C, Dowson A, Cooper ZA, Kumar R, Herbst RS. Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non-Small Cell Lung Cancer: Update From the COAST Randomized Clinical Trial , JAMA Netw Open, 8: 2025,e2518440
